Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX
about
Derivation of a triple mosaic adenovirus for cancer gene therapy.Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.Adenovirus receptors and their implications in gene deliveryDetection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review)Chapter two--Adenovirus strategies for tissue-specific targeting.Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunityCryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX.Transductional targeting of adenovirus vectors for gene therapyGenetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.Oncolytic adenoviruses - selective retargeting to tumor cells.Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.Current advances and future challenges in Adenoviral vector biology and targetingDynamin2 S-nitrosylation regulates adenovirus type 5 infection of epithelial cells.Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer modelTargeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.Replacement of native adenovirus receptor-binding sites with a new attachment moiety diminishes hepatic tropism and enhances bioavailability in mice.Adenoviral vector-based strategies for cancer therapy.Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy.A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction.A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting.Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostabilityConstruction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting.Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid.Designer Oncolytic Adenovirus: Coming of Age.
P2860
Q33521705-F0869E03-976E-4758-B00B-69500BD0DC6EQ33614622-02811923-8809-471E-8752-3332842D4476Q33994011-AE83AB4A-DB68-4762-AACB-D7378FD785DCQ34042482-8DB124DC-C093-41F6-866B-0864EB8B8430Q34120709-27DE2B3C-AEA5-46B4-B652-F6CFF8A2D0CBQ34433546-7EE42BC0-5ABB-43D0-8B48-1FF0C7458FB4Q34643252-14319468-B8EB-4BE2-A6DC-5983817E3776Q34648154-97B766A5-43FF-46A0-8133-130894CD184DQ35140014-3D7E2F81-F90F-4977-A51A-DB80B06339D7Q35609035-C62B2F8D-688C-46D3-AF3E-864F63EB6228Q35609066-586DC310-5699-4D42-832B-B3058E61841BQ36318189-408D0F35-8F10-4AC5-BDB5-C87BF2798CDDQ36330007-F244F7F9-EFD1-4848-8AFF-0AE266605646Q36463004-02F9B667-1638-41FE-BEA3-03663506AA0AQ36523197-2A1B5F94-C41D-4E65-9A46-957BFD29885FQ37127836-D76FC63A-64DD-4A82-9AB0-ADE5F7FA4608Q37227135-616837F9-2340-41E1-B087-BDF1EC033540Q37330624-CD29C28F-4C01-492A-B7D6-3630574CF1B0Q37409025-2A8F3ABE-8D4D-4179-A106-F35FAA38DFB8Q38241666-65FA6823-3288-45C9-BCCC-440968AD55D6Q38614156-C8D725A1-DFF3-45F2-A3E6-CF79E849CE4AQ38769919-825BDD5E-1027-4211-B5B6-62D5105ACBC4Q38983280-C5C961B7-98C3-4807-999A-51725085740CQ39455900-98A05991-54B2-4DA8-A731-DA524FCBB0BEQ39957922-81FF1637-E98E-44BD-A81E-29A61BC33B55Q40005191-4E5E24F9-FF56-4C10-891F-15C8A12DFF83Q40176311-9FFB72F5-7365-459E-A09E-B654950D1AD9Q40226617-73A7E6D4-095B-49EC-8D10-85B3EA590E81Q41056729-E2FA82EB-C101-4492-9C88-BAD6738427E6Q41875163-4E96CC35-6399-4CE5-B567-E6EA1FADC8C0Q42010270-2C84AE5E-231E-4351-BF5A-F5BC4CCABA14Q55467684-F7F860FA-47F2-4114-8345-25636C528C4F
P2860
Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Spacers increase the accessibi ...... ovirus minor capsid protein IX
@en
type
label
Spacers increase the accessibi ...... ovirus minor capsid protein IX
@en
prefLabel
Spacers increase the accessibi ...... ovirus minor capsid protein IX
@en
P2093
P2860
P50
P1433
P1476
Spacers increase the accessibi ...... ovirus minor capsid protein IX
@en
P2093
Diana J M van den Wollenberg
Frits J Fallaux
Hans Van der Meulen
Jort Vellinga
Martijn J W E Rabelink
Steve J Cramer
P2860
P304
P356
10.1128/JVI.78.7.3470-3479.2004
P407
P577
2004-04-01T00:00:00Z